JP Morgan Chase
ACH

JP Morgan Chase’s Accendra Health ACH Stock Holding History

JP Morgan Chase’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
30,689
+1,064
+4% +$3.31K ﹤0.01% 5991
2026
Q1 		$64K Sell
29,625
-1,451
-5% -$3.34K ﹤0.01% 6077
2025
Q4 		$87K Sell
31,076
-3,682
-11% -$13.2K ﹤0.01% 5963
2025
Q3 		$167K Sell
34,758
-66,619
-66% -$424K ﹤0.01% 5613
2025
Q2 		$923K Sell
101,377
-161,343
-61% -$1.19M ﹤0.01% 4432
2025
Q1 		$2.37M Sell
262,720
-225,777
-46% -$2.38M ﹤0.01% 3749
2024
Q4 		$6.38M Buy
488,497
+111,667
+30% +$1.49M ﹤0.01% 3126
2024
Q3 		$5.91M Buy
376,830
+152,999
+68% +$2.32M ﹤0.01% 3098
2024
Q2 		$3.02M Buy
223,831
+2,849
+1% +$58.3K ﹤0.01% 3436
2024
Q1 		$6.12M Sell
220,982
-12,246
-5% -$272K ﹤0.01% 2918
2023
Q4 		$4.49M Buy
233,228
+88,951
+62% +$1.61M ﹤0.01% 3186
2023
Q3 		$2.33M Sell
144,277
-11,334
-7% -$201K ﹤0.01% 3443
2023
Q2 		$2.96M Sell
155,611
-9,689
-6% -$173K ﹤0.01% 3260
2023
Q1 		$2.4M Buy
165,300
+18,273
+12% +$327K ﹤0.01% 3415
2022
Q4 		$2.87M Buy
147,027
+12,703
+9% +$248K ﹤0.01% 3281
2022
Q3 		$3.24M Sell
134,324
-308,316
-70% -$9.5M ﹤0.01% 3096
2022
Q2 		$13.9M Buy
442,640
+163,330
+58% +$5.92M ﹤0.01% 1907
2022
Q1 		$12.3M Sell
279,310
-52,193
-16% -$2.24M ﹤0.01% 2171
2021
Q4 		$14.4M Sell
331,503
-81,380
-20% -$3.19M ﹤0.01% 2113
2021
Q3 		$12.9M Buy
412,883
+12,130
+3% +$477K ﹤0.01% 2159
2021
Q2 		$17M Sell
400,753
-394,145
-50% -$15.3M ﹤0.01% 1991
2021
Q1 		$29.9M Buy
794,898
+274,416
+53% +$8.58M ﹤0.01% 1447
2020
Q4 		$14.1M Sell
520,482
-1,563,727
-75% -$40.2M ﹤0.01% 1918
2020
Q3 		$49M Sell
2,084,209
-901,891
-30% -$13.2M 0.01% 982
2020
Q2 		$22.8M Buy
2,986,100
+266,386
+10% +$1.95M ﹤0.01% 1288
2020
Q1 		$24.9M Sell
2,719,714
-2,439,416
-47% -$14.7M 0.01% 1123
2019
Q4 		$26.7M Buy
5,159,130
+382,431
+8% +$2.46M 0.01% 1368
2019
Q3 		$27.8M Buy
4,776,699
+1,912,455
+67% +$8.58M 0.01% 1344
2019
Q2 		$9.02M Sell
2,864,244
-60,566
-2% -$207K ﹤0.01% 2190
2019
Q1 		$12M Sell
2,924,810
-25,584
-0.9% -$162K ﹤0.01% 1892
2018
Q4 		$18.7M Buy
2,950,394
+1,354,757
+85% +$14.1M ﹤0.01% 1535
2018
Q3 		$26.4M Sell
1,595,637
-5,986
-0.4% -$102K 0.01% 1444
2018
Q2 		$26.8M Buy
1,601,623
+533,125
+50% +$8.63M 0.01% 1372
2018
Q1 		$16.6M Sell
1,068,498
-275,735
-21% -$4.92M ﹤0.01% 1656
2017
Q4 		$25.4M Sell
1,344,233
-160,908
-11% -$3.57M 0.01% 1404
2017
Q3 		$44.5M Sell
1,505,141
-33,969
-2% -$1M 0.01% 998
2017
Q2 		$49.5M Sell
1,539,110
-70,867
-4% -$2.33M 0.01% 915
2017
Q1 		$55.7M Buy
1,609,977
+929,196
+136% +$33.2M 0.01% 890
2016
Q4 		$24M Sell
680,781
-150,502
-18% -$5.09M 0.01% 1343
2016
Q3 		$28.9M Buy
831,283
+18,915
+2% +$662K 0.01% 1134
2016
Q2 		$30.4M Buy
812,368
+161,027
+25% +$6.05M 0.01% 1119
2016
Q1 		$26.3M Buy
651,341
+524,062
+412% +$19.5M 0.01% 1159
2015
Q4 		$4.58M Buy
127,279
+27,311
+27% +$988K ﹤0.01% 2277
2015
Q3 		$3.19M Sell
99,968
-18,433
-16% -$628K ﹤0.01% 2506
2015
Q2 		$4.03M Sell
118,401
-7,040
-6% -$237K ﹤0.01% 2526
2015
Q1 		$4.25M Sell
125,441
-160,820
-56% -$5.6M ﹤0.01% 2459
2014
Q4 		$10.1M Sell
286,261
-114,142
-29% -$3.84M ﹤0.01% 1941
2014
Q3 		$13.1M Sell
400,403
-27,295
-6% -$929K ﹤0.01% 1735
2014
Q2 		$14.5M Sell
427,698
-26,920
-6% -$922K ﹤0.01% 1522
2014
Q1 		$15.9M Buy
454,618
+10,394
+2% +$367K ﹤0.01% 1469
2013
Q4 		$16.2M Buy
444,224
+14,006
+3% +$514K ﹤0.01% 1459
2013
Q3 		$14.9M Buy
430,218
+80,208
+23% +$2.81M ﹤0.01% 1499
2013
Q2 		$11.8M Buy
+350,010
New +$11.6M ﹤0.01% 1567

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase's ACH Position: Q2 2026 in Review

JP Morgan Chase increased its Accendra Health (ACH) stake by 3.6% in Q2 2026, buying an estimated $3.31K and bringing the position to 30,689 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #5991.

JP Morgan Chase first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.7M in Q1 2017. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • JP Morgan Chase held 30,689 shares of Accendra Health worth $106K as of Q2 2026.
  • JP Morgan Chase bought 1,064 Accendra Health shares in Q2 2026, an estimated $3.31K.
  • Accendra Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5991 holding.
  • JP Morgan Chase first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Accendra Health position peaked at $55.7M in Q1 2017.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.